Results 121 to 130 of about 11,443 (285)
Sirolimus release from PLC-coated hemodialysis stent [PDF]
Hemodialysis vascular access dysfunction is the most significant cause of morbidity and hospitalisation in the hemodialysis industry. The main cause of hemodialysis vascular access dysfunction is venous stenosis incurred from neointimal hyperplasia ...
Lim, Aloysius Jun Hao
core
Properties of Uremic Solutes That Allow Their Effective Control by Hemodialysis
Key Points Hemodialysis can relieve uremic symptoms only by lowering the plasma levels of causative solutes below what they were at dialysis initiation.This can happen only when the ratio of a solute's dialytic clearance to the clearance of the failing kidney is very high.
Tanuja Yalamarti +6 more
openaire +2 more sources
Abstract Background Insomnia is highly prevalent, and non‐pharmacological strategies to facilitate sleep initiation remain an important clinical priority. Aims This study aimed to evaluate the tolerability, safety, and preliminary sleep‐related effects of a herbal aromatherapy liquid administered using a Traditional Chinese Medicine Aromatherapy Sleep ...
Huafeng Shan +8 more
wiley +1 more source
Hemodialysis Access Sites (HAS) and infection prevention [PDF]
Hemodialysis access sites are essential for the end stage renal disease patients for their treatment either long-term or short-term basis. These patients are in tremendous risk of infections due to invasive procedures on a regular basis and ...
Adhikari, Krishna, Aryan, Attaulhaq
core
Background Chronic Kidney Disease affects 13% of China’s population, with hemodialysis consuming 1–3% of national healthcare expenditure. Hemodialysis patients face complex physical-psychological burdens, while physicians in Traditional Chinese Medicine (
Yuxiu Jia +3 more
doaj +1 more source
Abstract Background It is clinically relevant to predict outcomes in dogs with acute kidney injury (AKI) treated with haemodialysis. The aim of this study was to evaluate the prognostic value of contrast‐enhanced ultrasound (CEUS) and its role in discriminating between AKI and acute impairment associated with chronic kidney disease (AKI/CKD).
Caterina Puccinelli +3 more
wiley +1 more source
Gut microbiota dysbiosis and Long COVID susceptibility in chronic kidney disease
This study investigated gut microbiota dysbiosis and its association with Long COVID susceptibility in 224 hemodialysis patients. We found that 35.3% of patients developed Long COVID, characterized by neurological symptoms and elevated inflammatory markers, accompanied by significant gut microbiota alterations including enriched proinflammatory taxa ...
Meiling Jin +5 more
wiley +1 more source
The current status and evolution of hemodialysis catheters
Chronic kidney disease (CKD) represents a growing global health burden, with an increasing number of CKD patients progressing to renal failure or end-stage renal disease (ESRD). Hemodialysis is widely regarded as the usual treatment modality for patients
Kanan Chen +3 more
doaj +1 more source
Abstract Introduction This study aims to investigate patient factors affecting the rate of plasma volume target attained in hypertriglyceridemic pancreatitis (HTG‐AP) patients undergoing double filtration plasmapheresis (DFPP). Methods A retrospective analysis of 82 HTG‐AP‐interpreted patients from January 2019 to April 2024 compared target plasma ...
Hui Zhang, Chenqiang Zhu, Yunlong Wu
wiley +1 more source
Objective To compare the occurrence of hypoglycemia during hemodialysis in chronic kidney disease diabetic patients who present different levels of pre-dialysis glycemia both when using dialysis solutions with and without glucose.
Jayme Eduardo Burmeister +3 more
doaj +1 more source

